The vaccine manufacturer Moderna sued Pfizer and BioNTech on Friday, claiming that its rivals’ Covid-19 shot violates its patents protecting its groundbreaking technology.Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology. Moderna, which is based in Cambridge, Mass., sued in U.S. District Court in Massachusetts and the Regional Court of Düsseldorf in Germany, where BioNTech is based.Christopher Ridley, a spokesman for Moderna, said the company did not have an estimate for the amount of damages it was seeking.Pfizer and its development partner BioNTech were “surprised by the litigation,” said Jerica Pitts, a spokeswoman for Pfizer. She added that the companies “remain confident in our intellectual prope …
Latest Business News
Orchestrating Value in Global Tourism and Hospitality (2/13/2026) - Orchestrating Value in Global Tourism and Hospitality The global tourism… Read more...
The Algorithmic Ocean: Structural Transformation and Artificial Intelligence Industrialization in the Global Cruise Sector (2/12/2026) - Algorithmic Waters: The Strategic Integration of AI in the Global… Read more...
AI’s New Horizon in the Travel Industry (2/12/2026) - AI's New Horizon in the Travel Industry The global travel… Read more...
AI and Technology Innovation Reshaping U.S. Tourism and Hospitality (1/30/2026) - AI and Technology Innovation Reshaping U.S. Tourism and HospitalityThe U.S.… Read more...
AI and Technology Innovation Reshaping Global E-Commerce in 2026 (1/30/2026) - AI and Technology Innovation Reshaping Global E-Commerce in 2026E-commerce has… Read more...
The Architecture of Autonomous Commerce (1/25/2026) - The Architecture of Autonomous Commerce - Strategic Evolution of AI… Read more...
Intelligent Capital: The Scenario Based Outlook for 2026 (1/25/2026) - Intelligent Capital Outlook 2026 The Scenario Based Outlook for 2026… Read more...
Unlocking Hidden Value: A New Secondary Market for Late Stage Rare Disease Therapies (1/19/2026) - Unlocking Hidden Value A New Secondary Market for Late Stage… Read more...